Rita Nanda to Neoplasms, Hormone-Dependent
This is a "connection" page, showing publications Rita Nanda has written about Neoplasms, Hormone-Dependent.
Connection Strength
0.183
-
TBCRC 002: a phase II, randomized, open-label trial of preoperative letrozole with or without bevacizumab in postmenopausal women with newly diagnosed stage 2/3 hormone receptor-positive and HER2-negative breast cancer. Breast Cancer Res. 2020 02 18; 22(1):22.
Score: 0.183